|
|
 News Archive
Profile Lead Compounds in Own Lab
08 Jul 2010: Promega Corporation has partnered with SignalChem Pharmaceuticals to launch a flexible and complete kinase solution for the profiling of lead compounds against kinases representative of all major families of the kinome. Through using this single platform, scientists can easily profile lead compounds in their own laboratories in a cost-effective manner with no loss in sensitivity.
Promega Corp.
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
adme-toxicology
